These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3194959)

  • 21. Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis.
    Dufour JF; Oneta CM; Gonvers JJ; Bihl F; Cerny A; Cereda JM; Zala JF; Helbling B; Steuerwald M; Zimmermann A;
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1537-43. PubMed ID: 17162245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bile acids in the therapy of chronic liver diseases].
    Sperandeo M; Varriale A; Sperandeo G; Carughi S; Lucentini L
    Recenti Prog Med; 1993 Mar; 84(3):225-30. PubMed ID: 8465104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The oral ursodeoxycholic acid test and its value in the diagnosis of liver diseases].
    Goszcz A
    Pol Tyg Lek; 1986 Apr; 41(17):547-51. PubMed ID: 3737462
    [No Abstract]   [Full Text] [Related]  

  • 24. Ursodeoxycholic acid and liver microsomal mixed function oxidase system in man.
    Di Padova C; Tritapepe R; Marabini L; Di Padova F; Rovagnati P; Mazzocchi M
    Methods Find Exp Clin Pharmacol; 1981; 3(4):209-11. PubMed ID: 7278432
    [No Abstract]   [Full Text] [Related]  

  • 25. [The effect of ursodeoxycholic acid in patients with liver cirrhosis and chronic hypertransaminasemia].
    Buongiorno G; Quaranta GM; Penna A; Guerra V; Misciagna G; Manghisi OG
    Minerva Gastroenterol Dietol; 1994 Mar; 40(1):31-6. PubMed ID: 8204703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Protein and pigment metabolism in the liver of patients with gallstones before and after treatment with cheno- and ursodeoxycholic acid preparations].
    Grebenev AL; Palinkashin DG; Genia LP; Golochevskaia VS; Lemeshko ZA
    Klin Med (Mosk); 1988 Mar; 66(3):96-9. PubMed ID: 3392933
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of the purified unsaponifiable fraction of soybean in combination with ursodeoxycholic acid on cholesterol saturation of bile and stone dissolution in gallstone patients.
    Kajiyama G; Kawamoto T; Fujiyama M; Maruhashi A; Miyoshi A
    Hiroshima J Med Sci; 1981 Jun; 30(2):71-83. PubMed ID: 7028684
    [No Abstract]   [Full Text] [Related]  

  • 28. [Drug therapy of cholelithiasis].
    Bansky G
    Schweiz Rundsch Med Prax; 1986 Mar; 75(12):333-8. PubMed ID: 3515488
    [No Abstract]   [Full Text] [Related]  

  • 29. [Balance of gallstone dissolution using drug therapy].
    Leuschner U
    Med Klin; 1981 Apr; 76(8):232-4. PubMed ID: 7231340
    [No Abstract]   [Full Text] [Related]  

  • 30. Ursodeoxycholic acid therapy in recurrent or acquired genotype II hepatitis C virus infection after liver transplantation: a three-case report.
    Kita Y; Beck Y; Teraoka S; Yokota K; Andoh Y; Nagao T; Gotoh M; Sakon M; Monden M
    Transplant Proc; 1996 Jun; 28(3):1701-3. PubMed ID: 8658847
    [No Abstract]   [Full Text] [Related]  

  • 31. [Ursodeoxycholic acid as anti-dyspeptic in surgically treated lithiasis].
    Polo M; Mastria CA
    Minerva Dietol Gastroenterol; 1985; 31(4):661-4. PubMed ID: 4088515
    [No Abstract]   [Full Text] [Related]  

  • 32. Medical treatment of gallstones: ursodeoxycholic acid.
    Drug Ther Bull; 1984 Feb; 22(4):13-5. PubMed ID: 6705691
    [No Abstract]   [Full Text] [Related]  

  • 33. Ursodeoxycholic acid in primary biliary cirrhosis.
    Bateson MC; Ross PE; Diffey BL
    Lancet; 1989 Apr; 1(8643):898-9. PubMed ID: 2564971
    [No Abstract]   [Full Text] [Related]  

  • 34. [Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard].
    Stiefelhagen P
    MMW Fortschr Med; 2007 May; 149(21):49. PubMed ID: 17668736
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical evaluation of ursodeoxycholic acid. Glucagon tolerance test in patients with chronic liver disease].
    Yamashita Y; Moriyasu F; Kimura T; Ono S; Kawasaki T; Tamada T; Ban N; Nakamura T; Uchino H
    Nihon Shokakibyo Gakkai Zasshi; 1988 Dec; 85(12):2651-7. PubMed ID: 3244182
    [No Abstract]   [Full Text] [Related]  

  • 36. [Further progress in the pharmacological dissolution of biliary calculi with ursodeoxycholic acid].
    Bojanowicz K; Witkowska A
    Wiad Lek; 1981 Aug; 34(16):1363-7. PubMed ID: 7340149
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of biliary lithiasis with ursodeoxycholic acid].
    Delmont J; Rampal P; Math M; Faure X; Renson M
    Sem Hop; 1980 Oct 18-25; 56(39-40):1613-6. PubMed ID: 6255580
    [No Abstract]   [Full Text] [Related]  

  • 38. [Ursodeoxycholic acid (UDCA) in the treatment of cholesterol cholelithiasis of the gallbladder and bile ducts].
    Goszcz A
    Pol Tyg Lek; 1983 Feb; 38(7):221-4. PubMed ID: 6346288
    [No Abstract]   [Full Text] [Related]  

  • 39. Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid.
    Tromm A; May B; Klein CG; Klein R; Fisseler-Eckhoff A; Griga T
    Hepatogastroenterology; 2005; 52(63):753-6. PubMed ID: 15966198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of portal and splenic vein shunts and impaired hepatic extraction in the elevated serum bile acids in liver cirrhosis.
    Ohkubo H; Okuda K; Iida S; Ohnishi K; Ikawa S; Makino I
    Gastroenterology; 1984 Mar; 86(3):514-20. PubMed ID: 6693014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.